A Nanopore Based Molnupiravir Sensor

ACS Sens. 2022 May 27;7(5):1564-1571. doi: 10.1021/acssensors.2c00447. Epub 2022 Apr 15.

Abstract

Nucleoside analogues are reagents that resemble the structure of natural nucleosides and are widely applied in antiviral and anticancer therapy. Molnupiravir, a recently reported nucleoside analogue drug, has shown its inhibitory effect against SARS-CoV-2. Rapid tracing of molnupiravir and its metabolites is important in the evaluation of its pharmacology effect, but direct sensing of molnupiravir as a single molecule has not been reported to date. Here, we demonstrate a nanopore-based sensor with which direct sensing of molnupiravir and its two major metabolites β-d-N4-hydroxycytidine and its triphosphate can be achieved simultaneously. In conjunction with a custom machine learning algorithm, an accuracy of 92% was achieved. This sensing strategy may be useful in the current pandemic and is in principle suitable for other nucleoside analogue drugs.

Keywords: Mycobacterium smegmatis porin A; molnupiravir; nucleoside analogues; programmable nanoreactors; single-molecule chemistry.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Drug Treatment*
  • Cytidine / analogs & derivatives
  • Humans
  • Hydroxylamines
  • Nanopores*
  • Nucleosides
  • SARS-CoV-2

Substances

  • Hydroxylamines
  • Nucleosides
  • Cytidine
  • molnupiravir